• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL CATD SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL CATD SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-21A
Device Problems Backflow (1064); Material Split, Cut or Torn (4008)
Patient Problems Aortic Regurgitation (1716); Dyspnea (1816); Heart Failure (2206)
Event Date 12/13/2019
Event Type  Injury  
Manufacturer Narrative
The results/ method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2015, a 21mm trifecta valve was implanted.On (b)(6) 2019, the valve was explanted due to regurgitation.Associated patient symptoms included dyspnea and heart failure.Upon explant, a hole was observed near one of the cusps.An unknown sized unknown device was successfully implanted.No patient consequences were reported.
 
Manufacturer Narrative
Explant was reported due to regurgitation.The investigation found that leaflets 2 and 3 contained a tear.All three leaflets had been previously dissected with excised tissue missing.All three leaflets were fibrotically thickened.There was fibrous pannus ingrowth on the outflow surface of leaflet 1.No inflammation or significant calcifications were present.The stent ring was distorted.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of the tear could not be conclusively determined; however, the fibrous pannus ingrowth noted had the potential to induce increased stress on adjacent leaflets and create an unbalanced stress relief distribution between all leaflets during coaptation, leading to leaflet tears and reduced durability.
 
Event Description
On (b)(6) 2015, a 21mm trifecta valve was implanted.On (b)(6) 2019, the valve was explanted due to regurgitation.Associated patient symptoms included dyspnea and heart failure.Upon explant, a hole was observed near one of the cusps.An unknown sized unknown device was successfully implanted.No patient consequences were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL CATD
4 robbins drive
westford MA 01886
MDR Report Key9569039
MDR Text Key174303904
Report Number3008452825-2019-00647
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052023
UDI-Public05414734052023
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Type of Report Initial,Followup,Followup
Report Date 03/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/26/2017
Device Model NumberTF-21A
Device Catalogue NumberTF-21A
Device Lot Number4980491
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/15/2020
Was the Report Sent to FDA? No
Date Manufacturer Received03/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-